financetom
Business
financetom
/
Business
/
Eaton's third-quarter profit beats Wall Street estimates but revenue lags
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eaton's third-quarter profit beats Wall Street estimates but revenue lags
Oct 31, 2024 4:56 AM

Oct 31 (Reuters) - Power management company Eaton

missed Wall Street expectations for third-quarter

revenue but marginally beat profit estimates on Thursday, with

slow residential construction offsetting strong sales of its

industrial equipment.

The worldwide proliferation of data centers, spurred by

businesses adopting artificial intelligence technologies, has

benefited Eaton, which manufactures electrical components for

these facilities.

However, sales for the Dublin, Ireland-based company's

industrial and construction components have been hurt by

builders hesitant to break new ground on housing projects due to

a rising supply of new homes on the market.

"We're confident in our ability to close the year strong

with raised earnings guidance and expect this positive momentum

to continue into 2025," Eaton CEO Craig Arnold said.

The company now expects its full-year adjusted earnings per

share to be in the range of $10.75 and $10.81 per share, above

Wall Street estimates of $10.67 per share.

Total revenue for the third quarter was $6.35 billion,

slightly below analysts' average expectations of $6.37 billion,

according to data compiled by LSEG.

Eaton reported an adjusted quarterly profit of $2.84 per

share, compared with analysts' estimates of $2.80 per share.

For the fourth quarter, the company anticipates adjusted

earnings per share to be between $2.78 and $2.84, with the

midpoint aligning with analysts' estimates of $2.81.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Centessa Pharmaceuticals Insider Sold Shares Worth $1,615,255, According to a Recent SEC Filing
Centessa Pharmaceuticals Insider Sold Shares Worth $1,615,255, According to a Recent SEC Filing
Dec 6, 2024
05:06 PM EST, 12/06/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on December 06, 2024, sold 87,496 shares in Centessa Pharmaceuticals ( CNTA ) for $1,615,255. Following the Form 4 filing with the SEC, Saha has control over a total of 613,661 shares of the company, with 575,661 shares held directly and 38,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000178/xslF345X05/wk-form4_1733522614.xml...
Turkey's Halkbank loses latest bid to avoid US prosecution in sanctions case
Turkey's Halkbank loses latest bid to avoid US prosecution in sanctions case
Dec 6, 2024
(Reuters) - A U.S. appeals court on Friday rejected a request by Turkey's Halkbank to reconsider a ruling holding that the U.S. Department of Justice could prosecute the state-owned bank on charges that it helped Iran evade American sanctions. The New York-based 2nd U.S. Circuit Court of Appeals declined to have the full court reconsider a three-judge panel's October rejection...
BioAge Labs Terminates Phase 2 Trial of Obesity Drug Candidate
BioAge Labs Terminates Phase 2 Trial of Obesity Drug Candidate
Dec 6, 2024
05:08 PM EST, 12/06/2024 (MT Newswires) -- BioAge Labs ( BIOA ) said late Friday it is terminating its phase 2 study of the investigational drug candidate azelaprag as both monotherapy and in combination with tirzepatide following observations of liver transaminitis in some subjects, without clinically significant symptoms. The company also noted that no transaminase elevations were detected in the...
Palantir, Anduril sign partnership for AI training in defense
Palantir, Anduril sign partnership for AI training in defense
Dec 6, 2024
(Reuters) - Data analytics firm Palantir Technologies ( PLTR ) and defense tech company Anduril Industries have partnered to use defense data for artificial intelligence training, the companies said on Friday. The partnership will leverage Palantir's ( PLTR ) AI platform to structure, label and prepare defense data for training to deploy those models onto national security systems, while Anduril's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved